Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Feb 9.
Published in final edited form as: Bone. 2009 Sep 3;46(1):81. doi: 10.1016/j.bone.2009.08.055

Inorganic pyrophosphatase induces type I collagen in osteoblasts

Monika D Polewski a, Kristen A Johnson b,1, Melissa Foster a, José Luis Millán c, Robert Terkeltaub a,*,1
Editor: J Aubin
PMCID: PMC2818162  NIHMSID: NIHMS146395  PMID: 19733704

Abstract

Introduction

The physiologic selectivity of calcification in bone tissue reflects selective co-expression by osteoblasts of fibrillar collagen I and of tissue nonspecific alkaline phosphatase (TNAP), which hydrolyzes the calcification inhibitor pyrophosphate (PPi) and generates phosphate (Pi). Humans and mice deficient in the PPi-generating ecto-enzyme NPP1 demonstrate soft tissue calcification, occurring at sites of extracellular matrix expansion. Significantly, the function in osteoblasts of cytosolic inorganic pyrophosphatase (abbreviated iPPiase), which generates Pi via PPi hydrolysis with neutral pH optimum, remains unknown. We assessed iPPiase in Enpp1−/− and wild type (WT) mouse osteoblasts and we tested the hypothesis that iPPiase regulates collagen I expression.

Methods

We treated mouse calvarial osteoblasts with ascorbate and β-glycerol phosphate to promote calcification, and we assessed cytosolic Pi and PPi levels, sodium-dependent Pi uptake, Pit-1 Pi co-transporter expression, and iPPiase and TNAP activity and expression. We also assessed the function of transfected Ppa1 in osteoblasts.

Results

Inorganic pyrophosphatase but not TNAP was elevated in Enpp1−/− calvariae in situ. Cultured primary Enpp1−/− calvarial osteoblasts demonstrated increased calcification despite flat TNAP activity rather than physiologic TNAP up-regulation seen in WT osteoblasts. Despite decreased cytosolic PPi in early culture, Enpp1−/− osteoblasts maintained cytosolic Pi levels comparable to WT osteoblasts, in association with increased iPPiase, enhanced sodium-dependent Pi uptake and expression of Pit-1, and markedly increased collagen I synthesis. Suppression of collagen synthesis in Enpp1−/− osteoblasts using 3,4-dehydroproline markedly suppressed calcification. Last, transfection of Ppa1 in WT osteoblasts increased cytosolic Pi and decreased cytosolic but not extracellular PPi, and induced both collagen I synthesis and calcification.

Conclusions

Increased iPPiase is associated with “Pi hunger” and increased calcification by NPP1-deficient osteoblasts. Furthermore, iPPiase induces collagen I at the levels of mRNA expression and synthesis and, unlike TNAP, stimulates calcification by osteoblasts without reducing the extracellular concentration of the hydroxyapatite crystal inhibitor PPi.

Keywords: PPi, Pi, Tissue-Nonspecific Alkaline Phosphatase, Calcification, Enpp1

Introduction

Osteoblasts deposit inorganic and organic components in an extracellular matrix (osteoid) specialized for calcification, with collagen I fibrils making up >90% of osteoid [1]. Moreover, physiologic restriction of calcification to bone tissue reflects selective co-expression of fibrillar collagen I and the ecto-enzyme tissue nonspecific alkaline phosphatase (TNAP) (EC 3.1.3.1) [2]. Extracellular Pi, under the systemic regulation of diet, renal and parathyroid function, and locally generated by TNAP in bone, directly promotes the deposition of the crystalline basic calcium phosphate hydroxyapatite [2]. This occurs in the spaced “hole regions” of triple helical fibrils of collagen I under the influence of non-collagenous proteins [3] as well as in chondrocyte- and osteoblast-derived matrix vesicles [4].

TNAP generates Pi both by ATPase activity and by hydrolyzing PPi, a potent physiologic inhibitor of hydroxyapatite crystal growth in the extracellular matrix [5]. Pi regulates calcification not simply by uptake in matrix vesicles, but also by effects on gene expression and the differentiation of mineralization-competent cells [6]. Pi uptake is mediated by multiple transporters, which include the sodium-dependent Pi co-transporters Pit-1 (SLC20A1, Glvr-1) and Pit-2 [7,8]. Pi functional effects are modulated by Pi-driven signaling via protein kinase C, Akt, and the MAP Kinase ERK1/ERK2 [9]. For example, direct provision of exogenous Pi, or of the TNAP substrate and organic Pi donor β-glycerophosphate modulates expression and nuclear transport of the osteoblastic master transcription factor Runx2 (cbfa1) [10,11], a promoter of collagen I expression (12) and essential driver of physiologic bone calcification [13]. Exogenous Pi also induces transcription of Pit-1, the hydroxyapatite crystal growth inhibitor and bone remodeling mediator osteopontin (OPN) [14], cyclin D1 [15], as well as certain transcription factors [6], including Nrf2 [16]. Exogenous Pi suppresses expression of mRNAs in osteoblasts that include those for tenascin-C, decorin, and certain collagens [16], and exogenous Pi post-transcriptionally regulates several proteins in osteoblasts including the AP-1 family transcription factor Fra-1 [6].

There has been only limited prior description of activity in bone [17] or in cultured osteoblasts [18] of the cytosolic enzyme inorganic pyrophosphatase, which generates Pi via PPi hydrolysis, with a neutral pH optimum (EC 3.6.1.1) [19]. Though inorganic pyrophosphatase activity has been reported to be substantial in osteoblasts [18], regulation and function of inorganic pyrophosphatase, unlike the case for TNAP, have not previously been characterized in osteoblasts. Extracellular PPi, including PPi associated with matrix vesicles, physiologically functions partly as a critical inhibitor of hydroxyapatite crystal growth [20]. However, intracellular PPi, like other phosphate esters, also serves as a biochemical intermediate and interacts with certain ATPases, modulates iron transport and mitochondrial function, and can regulate protein synthesis [20,21]. Deficiency in the PPi-generating ecto-enzyme NPP1 (EC 3.1.4.1) manifests with phenotypic features including significant alterations in bone mineralization in long bones and calvariae, and pathologic, severe soft tissue and arterial calcification, with marked expansion of extracellular matrix in the soft tissues of the tunica media (myointimal hyperplasia) at sites of pathologic calcification of large arteries as well as in perispinal soft tissues [22-26]. Hypophosphatemia corrects the pathologic soft tissue calcification in Enpp1−/− mice [2,5,24]. Furthermore, increased collagen synthesis has been observed in cultured osteoblasts from ttw/ttw mice, which are homozygous for a truncation mutation in Enpp1 and are phenotypically similar to Enpp1−/− mice [25]. Hence, we tested the hypothesis that the capacity of inorganic pyrophosphatase to hydrolyze cytosolic PPi to Pi could modulate both collagen I synthesis and calcification.

Materials and methods

Reagents

All chemical reagents were from Sigma-Aldrich, unless otherwise indicated.

Enpp1−/− mice and culture of primary osteoblasts

All animal studies were performed humanely by institutionally approved protocol. We employed Enpp1−/+ breeders backcrossed for >10 generations on C57BL/6 background, genotyping littermate wild type (WT) and Enpp1−/− newborns as described [23]. Primary calvarial osteoblasts were isolated from 0- to 3 -day-old mice [23], with osteoblasts of the same genotype pooled, and aliquots of 4 × 104 cells placed in a T75 tissue culture flask (BD Falcon) and carried in α-MEM (Cellgro/Mediatech) supplemented with 10% FCS, 2 mM glutamine, penicillin (50 U/ml), and streptomycin (0.5 mg/ml) (“Medium A”) at 37 °C in 5% CO2. To stimulate calcification, growth medium was supplemented with 50 μg/ml l-ascorbic acid-PO4 and 10 mM β-glycerophosphate (BGP) (“Medium B”), with medium replacement every 3 days.

Studies of cultured osteoblasts

Quantitative RT-PCR was performed as described [27], with quantification of target gene calculated by plotting crossing points on a Sybr Plus Green generated standard curve normalized to the quantification of a reference gene (GAPDH). PCR primers for murine cDNAs were: mouse collagen I α1 (Col1a1) (5′-TCT TTC CTT ATG AAT CAT CCC GCA-3′ and 5′-AAT TTC AAG CAC CCA TCT GTA G-3′), inorganic pyrophosphatase (Ppa1)(5′-CAA GGA CTT TGC AGT TGA CAT-3′ and 5′-ATG GCT TTG GCA GCA TC-3′), tissue non-specific alkaline phosphatase or TNAP (Akp2) (5′-AGA CAC AAG CAT TCC CAC TAT-3′ and 5′-CAC CAT CTC GGA GAG CG-3′), runt related transcription factor 2 (Runx2) (5′-GAT GCT CTG TTT CTT TCT TTC AGG-3′ and 5′-CTC CAG CAT TTC ATG CTA GT-3′), activating transcription factor 4 (Atf4) (5′-TTG ACC ACG TTG GAT GAC AC-3′ and 5′-CAG AGA TAT CAA CTT CAC TGC CTA-3′), osteocalcin (Bglap2) (5′-GTA GTG AAC AGA CTC CGG C-3′ and 5′-AGT GAT ACC GTA GAT GCG T-3′), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (5′-CAT CCC AGA GCT GAA CG-3′ and 5′-CTG GTC CTC AGT GTA GCC-3′).

To measure collagen synthesis, aliquots of 1.5 × 105 calcifying osteoblasts were incubated for 48 h at 37 °C, then 1.0 μCi 3H-Proline was added for 24 h, conditioned media collected, and collagenase-sensitive 3H incorporated determined [28], with data expressed as collagenase sensitive cpm/μg of protein. To specifically quantify cellular production of type I collagen, the collagen was first solubilized with pepsin under acidic conditions and then further digested with pancreatic elastase at neutral pH to convert polymeric to monomeric collagen, and measured (μg collagen/ml) by Collagen I Detection Kit (Chondrex).

To measure radiolabeled Pi uptake, we adapted an approach described in chondrocytes [29], here using aliquots of 1.5 × 105 osteoblasts. In brief, cells were incubated for 2 h at 37 °C in Pi-free buffer (1 mM CaCl2, 1.8 mM MgCl2, and 10 mM HEPES), then assays initiated by adding 200 μl of the Pi-free buffer also containing 3 μCi/ml carrier-free 33Pi (MP Biomedicals) and 150 mM NaCl. After 5 min, uptake was terminated by medium replacement with ice cold Pi-free buffer [29]. Results for Pi uptake were normalized per cell DNA. We assessed Pit-1 expression by SDS-PAGE/Western blotting as described, using a rabbit polyclonal Pit-1 specific antibody [29].

To assess calcification, osteoblasts (75,000 cells/well) were cultured in Medium B, and von Kossa staining nodules quantified in a minimum of 5 high power fields [26] or Alizarin Red S binding assay performed [23]. For immunocytochemical analyses, cells fixed with 4% paraformaldehyde were studied using the Histomouse-SP kit (Zymed) and employed the DAB chromogen/substrate system to detect antigen/antibody/enzyme complex as intense brown deposits, with hematoxylin QS (Vector Laboratories) as counterstain. Primary antibody (rabbit anti-mouse collagen I (Chemicon) (1:50) was incubated with sections for 1 h. Nonimmune rabbit IgG (Santa Cruz Biotechnology) was the negative control.

Inorganic pyrophosphatase transfection, iPPiase activity, alkaline phosphatase activity and intracellular Pi and PPi assays

For measurement of cytosolic Pi, we adapted a described assay [30], in which cells were washed with 10 mM PBS and their cytosolic content extracted using the Subcellular Proteome Extraction Kit (Calbiochem) according to manufacturer protocol. Pi was measured colorimetrically at OD620 using the PiBlue Phosphate Assay Kit (BioAssay Systems). Data were expressed as pmoles of Pi per μg protein in each well. Due to the low sample volumes recovered from cytosol, PPi was measured radiometrically [23] in separate sets of cytosolic extracts. Extracellular PPi was measured in parallel in conditioned media [23] collected from each well.

We transfected osteoblasts with human iPPiase cDNA subcloned into pBSSK from Dr. T. Wensel (Baylor) [19]. To do so, aliquots of 3 × 105 primary calvarial osteoblasts were placed in Medium B as above, and on day 10 of culture were transiently transfected using Targefect-Osteoblast (Targeting Systems) according to manufacturer protocol. Control transfection efficiency in each experiment was determined by β-galactosidase transfection and staining, and was consistently >30–40%. To assay iPPiase activity, cells were resuspended in 50 mM Glycine, 10 mM MgCl2 and incubated with Taussky-Shor Color Reagent at 50 °C for 10 min, with enzymatic activity assessed colorimetrically at OD 660 nm [31]. Five micrograms of protein was used to colorimetrically measure alkaline phosphatase (AP) specific activity with 5 mM p-nitrophenolphosphate used as a substrate. One unit of AP was defined as 1 μmol substrate hydrolyzed per hour (per microgram protein/sample).

Statistics

Data are expressed as mean ± SD, unless otherwise noted. Statistically significant differences between two groups were determined by 2-tailed unpaired Student's t-test, or by 1-way ANOVA to compare means between >3 experimental sample groups.

Results

iPPiase is increased in Enpp1−/− calvariae in situ

We first established specificity of assays for alkaline phosphatase and iPPiase enzyme activity (Supplemental Fig. 1). Using these assays, we demonstrated that Enpp1−/− calvariae had elevated iPPiase activity and Ppa1 mRNA levels, whereas alkaline phosphatase activity and Akp2 mRNA expression were not significantly altered in situ (Figs. 1A–D).

Fig. 1.

Fig. 1

Increased Ppa1 expression and iPPiase activity in situ in Enpp1−/− calvariae. In freshly isolated mouse calvariae of the indicated genotypes, (A) inorganic pyrophosphatase 1 (Ppa1) and (B) TNAP (Akp2) mRNA expression were quantified by real-time PCR and normalized to the housekeeping gene Gapdh, using the LightCycler FastStart DNA Master Plus SYBR Green system. Six samples per run were averaged for the above results. (C) Inorganic pyrophosphatase 1 (abbreviated as iPPiase here and in other figure labels) and alkaline phosphatase (D) activity were measured in freshly isolated calvariae, as described in Methods, with data expressed as Units per μg protein (n = 5). *p <0.05.

Cultured Enpp1−/− osteoblasts maintain cytosolic Pi levels comparable to normal osteoblasts and demonstrate increased calcification despite decreased TNAP

Assessing primary mouse calvarial osteoblasts, stimulated to calcify by treatment with ascorbate and the organic phosphate donor β-glycerophosphate (10 mM), we first confirmed [23] a 2- to 4-fold increase in calcification between 10 and 18 days in Enpp1−/− osteoblasts (data not shown). Under these conditions, Ppa1 mRNA expression and iPPiase activity were greater in calcifying Enpp1−/− than WT osteoblasts in cells at several time points, though elevation of iPPiase activity in Enpp 1−/− cells principally occurred in the first few days (Figs. 2A, B). In contrast, WT osteoblasts were confirmed [32] to have significant elevations in both Akp2 mRNA expression and alkaline phosphatase activity (Figs. 2C, D).

Fig. 2.

Fig. 2

Comparison of iPPiase, cytosolic PPi and Pi levels, and alkaline phosphatase in Enpp1−/− and WT osteoblasts. (A) Ppa1 expression relative to Gapdh and (B) whole cell iPPiase activity were measured in calvarial osteoblasts stimulated to calcify using 10 mM BGP and 50 μg/ml ascorbate, as described in Methods (n = 6). (C) Akp2 mRNA (n = 6) and (D) whole cell alkaline phosphatase activity (n = 4) were measured in primary calvarial osteoblasts, as described in Methods. (E) Cytosolic PPi was measured radiometrically (n = 5), and (F) cytosolic Pi measured colorimetrically at OD620 (data pooled for 3 separate experiments run in quadruplicate). *p<0.05.

Since Pi and PPi levels are modulated by iPPiase and TNAP, we examined cytosolic PPi and Pi levels in the calcifying osteoblasts. Enpp1−/− osteoblasts demonstrated ~3-fold less cytosolic PPi at day 1 in culture, but the Enpp1−/− osteoblasts maintained cytosolic Pi levels at comparable levels to those of WT osteoblasts between days 1 and 14 in culture (Figs. 2E, F), under conditions where the hypercalcifying Enpp1−/− osteoblasts did not mount a rise in either Akp2 mRNA expression or alkaline phosphatase activity (Figs. 2C, D).

In association with maintenance of cytosolic Pi levels comparable to WT osteoblasts in Enpp1−/− cells, sodium-dependent Pi uptake sensitive to blunting by sodium-dependent Pi co-transporter inhibitor phosphonoformic acid (PFA) [29] was increased several-fold in Enpp1−/− compared to WT osteoblasts at days 4 and 14 (Fig. 3A). Under these conditions, detectable expression of the sodium-dependent Pi co-transporter Pit-1 (by SDS-PAGE/Western blotting) was more sustained in the Enpp1−/− osteoblasts (Fig. 3B).

Fig. 3.

Fig. 3

Sodium-dependent Pi uptake is increased and the sodium-dependent Pi co-transporter Pit-1 expression more sustained in Enpp1−/− compared to WT primary calvarial osteoblasts. (A) 33Pi uptake was quantified in osteoblasts with and without treatment with the sodium-dependent Pi co-transporter inhibitor phosphonoformic acid (PFA) (300 μM), as described in Methods (n = 4). (B) Pit-1 (~85–90 kDa) was assessed by SDS-PAGE/Western blotting of osteoblast cell lysates induced to calcify, using rabbit antibodies to Pit-1 and to tubulin as a control. *p <0.05.

Increased Runx2, ATF4 and collagen I expression in cultured Enpp1−/− osteoblasts

Elevation of TNAP expression is one marker of osteoblast maturation [32], as is increase in osteocalcin (Bglap2) and the Pi-sensitive osteoblast master transcription factor Runx2. However, there was no significant alteration in the onset or extent of elevation in expression of Bglap2 [33] as Enpp1−/− osteoblasts carried out calcification in vitro (Fig. 4A). The Enpp1−/− osteoblasts demonstrated increased expression of Runx2 (Fig. 4B), one of several transcription factors that promote osteoblast collagen I expression [12] as well as expression of ATF4, a key transcription factor regulating osteocalcin expression (Fig. 4C). Type I collagen production, assessed by immunocytochemistry, and total synthesis of collagen were increased in calcifying Enpp1−/− osteoblasts relative to WT cells (Figs. 5A, B), but differences in Col1a1 mRNA expression did not reach statistical significance during the same course of osteoblast differentiation (not shown). Increased collagen synthesis in Enpp1−/− osteoblasts was reversed by treatment with exogenous PPi (Fig. 5B).

Fig. 4.

Fig. 4

Comparison of expression of osteocalcin, runx2, and Atf4 in Enpp1−/− and WT osteoblasts. (A-C) Osteocalcin (Bglap2), Runx2, and ATF4 were quantified and normalized to Gapdh by real-time PCR in calvarial osteoblasts treated with 10 mM BGP and 50 μg/ml ascorbate acid (n = 6).

Fig. 5.

Fig. 5

Comparison of expression of type I collagen and collagen synthesis in Enpp1−/− and WT osteoblasts. (A) Immunocytochemistry of the calcifying osteoblasts using rabbit anti-mouse collagen I-specific antibody and negative staining control (nonimmune rabbit IgG). Magnification, 100×. (B) Total collagen synthesis was measured by 3H-proline incorporation into osteoblasts grown for 72 h days in the same medium as above, with and without exogenous PPi added, and results expressed as collagenase sensitive cpm/μg DNA. *p<0.05.

Increased iPPiase induces collagen I expression and calcification in osteoblasts

Treatment of Enpp1−/− osteoblasts with the collagen synthesis inhibitor 3,4-dehydroproline, which was confirmed [34] to suppress total collagen synthesis (data not shown), inhibited collagen I deposition in the extracellular matrix (Fig. 5A), and inhibited calcification by up to ~50% in both Enpp1−/− and WT osteoblasts (Fig. 6B). Since increased type I collagen appeared intimately involved in the hypercalcification process in Enpp1−/− osteoblasts, we next tested the hypothesis that type I collagen was directly regulated by iPPiase. To do so, we transfected Ppa1 cDNA into normal osteoblasts, and observed association of ~50% more cell-associated iPPiase activity with ~100% higher cytosolic Pi and with ~6-fold lower cytosolic PPi (Figs. 7A-C). Under these conditions, iPPiase did not significantly lower the concentration of extracellular PPi (Fig. 7D). Nevertheless, Ppa1 transfection induced calcification (visualized as several-fold increased von Kossa positive nodule formation) (Figs. 7E, F).

Fig. 6.

Fig. 6

Inhibition of collagen synthesis in Enpp1−/− osteoblasts markedly suppresses calcification. (A) WT and Enpp1−/− osteoblasts grown in medium containing 10 mM BGP and 50 μg/ml ascorbate and 1.0 mM dehydro-l-proline for 72 h were studied by immunocytochemistry for type I collagen, using nonimmune rabbit IgG antibody as negative control. Magnification, 100×. Representative scale bar indicates 400 μ. (B) WT and Enpp1−/− osteoblasts were treated with 10 mM BGP and 50 μg/ml ascorbate, as well as 0.1 mM and 1.0 mM dehydro-l-proline for 72 h. Calcification was quantified by Alizarin Red S binding, determined chromogenically at OD570. *p<0.05.

Fig. 7.

Fig. 7

Effects of Ppa1 transfection on cytosolic Pi and PPi and extracellular PPi levels, and on calcification in WT primary calvarial osteoblasts. WT osteoblasts grown in medium supplemented with 10 mM BGP and 50 μg/ml ascorbate were transfected at day 10 in culture and assayed 72 h later. (A) iPPiase activity was measured and expressed as Units per microgram protein. (B) Cytosolic Pi, (C) cytosolic PPi, and (D) extracellular PPi were measured. (E) Calcification was assessed by von Kossa staining, with counterstaining using nuclear fast red, and representative staining results shown. Calcium salts appear brown-black. Magnification, 200×. Representative scale bar indicates 500 μ. (F) von Kossa positive nodules per high-power field were counted after transfection by a blinded observer. Mean ± SD, representative of 6 individual fields. *p<0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

The Ppa1 transfection did not modulate expression of the transcription factor ATF4 (Figs. 8A, B), which critically promotes collagen I expression as well as osteoblast maturation and terminal differentiation in vitro and is essential for promoting accrual of the normal mass of calcified bone in vivo [35]. Nevertheless, Ppa1 transfection induced Col1a1 mRNA (Fig. 8C) in association with increased collagen I synthesis (Figs. 8D, E). Our findings are summarized in the model of Supplementary Fig. 2, and discussed further below.

Fig. 8.

Fig. 8

iPPiase induces type I collagen expression in primary calvarial osteoblasts without significantly modulating ATF4 expression. WT osteoblasts grown in medium supplemented with 10 mM BGP and 50 μg/ml ascorbate acid were transfected with Ppa1 at day 10 and assayed 72 h later. (A, B) ATF4 mRNA and protein expression were assessed by real-time PCR and Western blotting, respectively (n = 4). (C) Col1a1 mRNA was measured by real-time PCR and (D) capture ELISA performed for collagen I, as described in Methods, with results expressed μg collagen I/ml (n = 8). *p<0.05. (E) Immunocytochemistry for collagen I, as described above was performed after iPPiase transfection. Magnification, 100×. Representative scale bar indicates 400 μ.

Discussion

Osteoblast PPi and Pi metabolism are subject to regulation coordinated partly via NPP1-catalyzed intracellular and extracellular PPi generation, predominant cytosolic to extracellular movement of PPi driven by ANK, and PPi hydrolysis by TNAP [2,5,20,23,24,30]. Linkage of these events can modulate the effects of these and other regulators of calcification [23,24,36,37]. For example, PPi inhibits the enzymatic activity of alkaline phosphatase [37], and both exogenous PPi and Pi induce osteopontin (OPN) expression [23,24,37].

Certain regulators of PPi and Pi metabolism have been observed to be modulated at the expression level in PPi deficiency states [24,38,39], and here, we observed that Ppa1 expression and iPPiase activity were increased in situ in Enpp1−/− mice calvariae previously documented to have a primary deficiency of PPi generation [23]. Moreover, there were early increases in Ppa1 expression and activity of iPPiase in hypercalcifying Enpp1−/− cultured calvarial osteoblasts relative to WT osteoblasts. Other abnormalities in Pi metabolism observed in calcifying Enpp1−/− osteoblasts were lack of the typical increase in TNAP at 10 days and greater in culture seen in normal cells, as well as more sustained Pit-1 expression and increased sodium-dependent Pi uptake. Expression of the Pi-regulated osteoblast master transcription factor Runx2 also was increased in cultured Enpp1−/− osteoblasts.

The maintenance of cytosolic Pi levels comparable to those of WT osteoblasts in Enpp1−/− osteoblasts, despite lack of increased TNAP Pi-generating PPi-hydrolyzing and ATPase activities in Enpp1−/− osteoblasts, suggested contributory effects of both early increases in iPPiase activity and sustained elevation of sodium-dependent Pi uptake (essentially increased “Pi hunger”). The marked decrease in cytosolic PPi early in culture in Enpp1−/− osteoblasts observed here may have partially reflected adaptive increases in iPPiase activity. We did not test for changes in PPi transport by Ank [40] or for altered PPi generation by the NPP3 isoenzyme [41].

Pit-1-driven Pi uptake is known to promote calcification by osteoblasts and vascular smooth muscle cells [7,8]. Here, we demonstrated that increased iPPiase, which lowered cytosolic PPi (but not extracellular PPi) levels in association with elevation of cytosolic Pi, also increased collagen I mRNA and collagen I synthesis, as well as calcification in normal osteoblasts. Pathologic calcification of perispinal ligaments and certain other soft tissues in association with NPP1 deficiency is intimately linked with marked extracellular matrix expansion [22,23]. Here, we observed increased collagen I production by Enpp1−/− osteoblasts. The induction by iPPiase of collagen I in osteoblasts was not dependent on modulation of ATF4 expression [35], and therefore may have partly reflected direct effects of cytosolic Pi. In this context, intracellular Pi has been observed to provide signals that affect mitochondrial function and intracellular movement of Runx2 in chondroosseous differentiation [10,42], and Pi regulates expression of multiple genes that modulate calcification [6,9,14-16].

Since cytosolic Pi levels were not elevated in PPi-depleted Enpp1−/− osteoblasts compared to wild type cells, we speculate that ambient cytosolic PPi regulates cytosolic Pi signaling potential and impacts on Pi-sensitive gene expression. Alternatively, the subcellular loci for PPi and Pi generation and transport may modulate distinct signaling and transcriptional regulatory effects of Pi. Exogenous Pi down-regulates collagen I expression in murine immortalized calvarial osteoblastic MC3T3-E1 cells [16]. As such, Pi effects on osteoblast determinants of osteoid composition may also depend on timing of administration in relation to osteoblast differentiation. However, transfection of Ppa1 did not act by affecting osteoblast extracellular PPi. It will be of interest to assess the net role increased iPPiase plays in extracellular matrix expansion at sites of pathologic soft tissue calcification in Enpp1−/− mice.

Significantly, Ank, which lowers intracellular PPi [40], promotes osteoblast maturation [43]. However, factors other than cytosolic PPi and balance may contribute to increasing Runx2, Pit-1, and collagen Pi I expression in Enpp1−/− osteoblasts that demonstrate decreases in cytosolic PPi. For example, Enpp1-deficient murine ttw/ttw osteoblasts demonstrate enhanced PTH responsiveness and collagen synthesis in culture [25], and PTH regulates Runx2 expression, and PTH anabolic effects in bone require Runx2 [44]. Cellular sodium-dependent Pi uptake not only is induced by Pi deprivation but also is modulated by IGF-I [45,46]. In this context, NPP1 is known to antagonize receptor signaling by insulin in a PPi-independent manner [47], and insulin receptor and IGF-I receptor signaling partially overlap.

Limitations of this study included temporal compression of the experimental analyses by adding 4-fold more β-glycerophosphate to stimulate calcification than in our previous study of Enpp1−/− osteoblasts (10 mM vs. 2.5 mM) [23]. Nevertheless, we have observed a blunting of the normal rise in alkaline phosphatase activity as Enpp1−/− osteoblasts are stimulated to calcify over 2–3 weeks in culture via addition of as little as 2.5 mM β-glycerophosphate (Johnson KA, et al., unpublished observations). We did not study modulation by iPPiase of proteins other than collagen that play substantial roles in modulating hydroxyapatite crystal nucleation and growth [1,23,24,48]. Last, PFA effectively inhibits class II sodium-dependent Pi co-transporters but is not a potent inhibitor of class III Pit-1-mediated Pi co-transport [49], and this study did not perform experiments to specifically knock down Pit-1 or other sodium-dependent Pi co-transporters.

In conclusion, pathologic calcification in NPP1 deficiency states may be mediated by increased hunger of mineralizing PPi-deficient cells for Pi. In turn, increased Pi generation by iPPiase and increased Pi uptake mediated by Pit-1 function to normalize cytosolic Pi levels in cells deficient in NPP1 and PPi, and such cells respond with heightened Runx2 and collagen I expression. Our results implicate increased collagen I expression in osteoblastic cells in promoting the marked extracellular matrix expansion documented in association with NPP1 deficiency in soft tissues containing ectopic chondroosseous differentiation and calcification. Increased collagen I expression by Enpp1−/− osteoblastic cells may do more to promote calcification than simply providing more extracellular matrix loci for hydroxyapatite deposition. For example, the capacity of a type I collagen-rich extracellular matrix to induce integrin-mediated osteoblastic differentiation [50,51] may promote the dysregulated chondro-osseous differentiation seen in soft tissues in association with NPP1 deficiency [39]. Type I collagen supports maintenance of osteoblast phenotype [32], promoting increased expression of several genes that modulate differentiation in osteoblastic cells (e.g., PTH/PTHrP receptor [32,52,53]. Taken together, the results of this study shed new light on the fundamental role in calcification of the interface between extracellular matrix composition and closely linked PPi and Pi metabolism. Though TNAP appears to be in charge of controlling the steady state Pi:PPi ratio extracellularly that regulates matrix calcification, iPPiase could be central to appropriate balance of steady state intracellular Pi relative to its potential inhibitor PPi,. Functional relationships between imbalances in Pi relative to PPi in different subcellular compartments merit further investigation.

Supplementary Material

Supp Figures
1

Acknowledgments

Funded by the VA Research Service, NIH grants HL077360, AR049366, PAG07998, and AR047908.

Appendix A. Supplementary data

Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.bone.2009.08.055.

References

  • 1.Thorwarth M, Wehrhan F, Schultze-Mosgau S, Wiltfang J, Schlegel KA. PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation. Bone. 2006;38:30–40. doi: 10.1016/j.bone.2005.06.020. [DOI] [PubMed] [Google Scholar]
  • 2.Murshed M, Harmey D, Millán JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005;19:1093–104. doi: 10.1101/gad.1276205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gajjeraman S, Narayanan K, Hao J, Qin C, George A. Matrix macromolecules in hard tissues control the nucleation and hierarchical assembly of hydroxyapatite. J Biol Chem. 2007;282:1193–204. doi: 10.1074/jbc.M604732200. [DOI] [PubMed] [Google Scholar]
  • 4.Roberts S, Narisawa S, Harmey D, Millán JL, Farquharson C. Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res. 2007;22:617–27. doi: 10.1359/jbmr.070108. [DOI] [PubMed] [Google Scholar]
  • 5.Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A. 2002;99:9445–9. doi: 10.1073/pnas.142063399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, Yu LR, et al. A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol Cell Proteomics. 2005;4:1284–96. doi: 10.1074/mcp.M500082-MCP200. [DOI] [PubMed] [Google Scholar]
  • 7.Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 2008;199:271–7. doi: 10.1016/j.atherosclerosis.2007.11.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, et al. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res. 2006;21:674–83. doi: 10.1359/jbmr.020603. [DOI] [PubMed] [Google Scholar]
  • 9.Beck GR, Jr, Knecht N. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem. 2003;278:41921–9. doi: 10.1074/jbc.M304470200. [DOI] [PubMed] [Google Scholar]
  • 10.Fujita T, Izumo N, Fukuyama R, Meguro T, Nakamuta H, Kohno T, et al. Phosphate provides an extracellular signal that drives nuclear export of Runx2/Cbfa1 in bone cells. Biochem Biophys Res Commun. 2001;280:348–52. doi: 10.1006/bbrc.2000.4108. [DOI] [PubMed] [Google Scholar]
  • 11.Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89:1147–54. doi: 10.1161/hh2401.101070. [DOI] [PubMed] [Google Scholar]
  • 12.Kern B, Shen J, Starbuck M, Karsenty G. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem. 2001;276:7101–7. doi: 10.1074/jbc.M006215200. [DOI] [PubMed] [Google Scholar]
  • 13.Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747–54. doi: 10.1016/s0092-8674(00)80257-3. [DOI] [PubMed] [Google Scholar]
  • 14.Beck GR, Jr, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A. 2000;97:8352–7. doi: 10.1073/pnas.140021997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Conrads KA, Yu LR, Lucas DA, Zhou M, Chan KC, Simpson KA, et al. Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells. Electrophoresis. 2004;25:1342–52. doi: 10.1002/elps.200405892. [DOI] [PubMed] [Google Scholar]
  • 16.Beck GR, Jr, Moran E, Knecht N. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res. 2003;288:288–300. doi: 10.1016/s0014-4827(03)00213-1. [DOI] [PubMed] [Google Scholar]
  • 17.Oata M, Orimo H, Fujita T, Yoshikawa M. Properties of rat bone inorganic pyrophosphatase studied by means of 32P-radioassay. J Biochem. 1971;70:1003–10. doi: 10.1093/oxfordjournals.jbchem.a129709. [DOI] [PubMed] [Google Scholar]
  • 18.Shaw KY, Tang JS, Chao CF. Functional evaluation of cultured rabbit osteoblast-like cells. Proc Natl Sci Counc Repub China. 1989;B 13:192–200. [PubMed] [Google Scholar]
  • 19.Yang Z, Wensel TG. Molecular cloning and functional expression of cDNA encoding a mammalian inorganic pyrophosphatase. J Biol Chem. 1992;267:24641–7. [PubMed] [Google Scholar]
  • 20.Terkeltaub RA. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol, Cell Physiol. 2001;281:C1–11. doi: 10.1152/ajpcell.2001.281.1.C1. [DOI] [PubMed] [Google Scholar]
  • 21.Mansurova SE. Inorganic pyrophosphate in mitochondrial metabolism. Biochem Biophys Acta. 1989;977:237–47. doi: 10.1016/s0005-2728(89)80078-7. [DOI] [PubMed] [Google Scholar]
  • 22.Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, et al. Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet. 2003;34:379–81. doi: 10.1038/ng1221. [DOI] [PubMed] [Google Scholar]
  • 23.Johnson K, Goding J, Van Etten D, Sali A, Hu SI, Farley D, et al. Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res. 2003;18:994–1004. doi: 10.1359/jbmr.2003.18.6.994. [DOI] [PubMed] [Google Scholar]
  • 24.Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol. 2004;164:1199–209. doi: 10.1016/S0002-9440(10)63208-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Terakado A, Tagawa M, Goto S, Yamazaki M, Moriya H, Fujimura S. Elevation of alkaline phosphatase activity induced by parathyroid hormone in osteoblast-like cells from the spinal hyperostotic mouse TWY (twy/twy). Calcif Tissue Int. 1995;56:135–9. doi: 10.1007/BF00296345. [DOI] [PubMed] [Google Scholar]
  • 26.Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, et al. Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol. 2005;166:1711–20. doi: 10.1016/S0002-9440(10)62481-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Johnson KA, Polewski M, Terkeltaub RA. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res. 2008;102:529–37. doi: 10.1161/CIRCRESAHA.107.154260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum. 2000;43:1560–70. doi: 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • 29.Cecil DL, Rose DM, Terkeltaub R, Liu-Bryan R. Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes. Arthritis Rheum. 2005;52:144–54. doi: 10.1002/art.20748. [DOI] [PubMed] [Google Scholar]
  • 30.Wang W, Xu J, Du B, Kirsch T. Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol. 2005;25:312–23. doi: 10.1128/MCB.25.1.312-323.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Taussky HH, Shorr E. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem. 1953;202:675–85. [PubMed] [Google Scholar]
  • 32.Lynch MP, Stein JL, Stein GS, Lian JB. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res. 1995;216:35–45. doi: 10.1006/excr.1995.1005. [DOI] [PubMed] [Google Scholar]
  • 33.Pockwinse SM, Wilming LG, Conlon DM, Stein GS, Lian JB. Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem. 1992;49:310–23. doi: 10.1002/jcb.240490315. [DOI] [PubMed] [Google Scholar]
  • 34.D'Alonzo RC, Kowalski AJ, Denhardt DT, Nickols GA, Partridge NC. 2002 Regulation of collagenase-3 and osteocalcin gene expression by collagen and osteopontin in differentiating MC3T3-E1 cells. J Biol Chem. 2002;277:24788–98. doi: 10.1074/jbc.M202604200. [DOI] [PubMed] [Google Scholar]
  • 35.Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin–Lowry Syndrome. Cell. 2004;117:387–98. doi: 10.1016/s0092-8674(04)00344-7. [DOI] [PubMed] [Google Scholar]
  • 36.Rutherford RB, Foster BL, Bammler T, Beyer RP, Sato S, Somerman MJ. Extracellular phosphate alters cementoblast gene expression. J Dent Res. 2006;85:505–9. doi: 10.1177/154405910608500605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Addison WN, Azari F, Sørensen ES, Kaartinen MT, McKee MD. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem. 2007;282:15872–83. doi: 10.1074/jbc.M701116200. [DOI] [PubMed] [Google Scholar]
  • 38.Harmey D, Johnson KA, Zelken J, Camacho NP, Hoylaerts MF, Noda M, et al. Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res. 2006;21(9):1377–86. doi: 10.1359/jbmr.060619. [DOI] [PubMed] [Google Scholar]
  • 39.Johnson K, Polewski M, van Etten D, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Thromb Vasc Biol. 2005;25:686–91. doi: 10.1161/01.ATV.0000154774.71187.f0. [DOI] [PubMed] [Google Scholar]
  • 40.Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000;289:265–70. doi: 10.1126/science.289.5477.265. [DOI] [PubMed] [Google Scholar]
  • 41.Vaingankar SM, Fitzpatrick TA, Johnson K, Goding JW, Maurice M, Terkeltaub R. Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1. Am J Physiol, Cell Physiol. 2004;286:C1177–87. doi: 10.1152/ajpcell.00320.2003. [DOI] [PubMed] [Google Scholar]
  • 42.Mansfield K, Pucci B, Adams CS, Shapiro IM. Induction of apoptosis in skeletal tissues: phosphate-mediated chick chondrocyte apoptosis is calcium dependent. Calcif Tissue Int. 2003;73:161–72. doi: 10.1007/s00223-002-1056-z. [DOI] [PubMed] [Google Scholar]
  • 43.Kirsch T, Kim HJ, Winkles JA. Progressive ankylosis gene (ank) regulates osteoblast differentiation. Cells Tissues Organs. 2008 Aug 26; doi: 10.1159/000151725. [electronic publication ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Krishnan V, Moore TL, Ma YL, Helvering LM, Frolik CA, Valasek KM, et al. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol. 2003;17:423–35. doi: 10.1210/me.2002-0225. [DOI] [PubMed] [Google Scholar]
  • 45.Ernest S, Coureau C, Escoubet B. Deprivation of phosphate increases IGF-II mRNA in MDCK cells but IGFs are not involved in phosphate transport adaptation to phosphate deprivation. J Endocrinol. 1995;145:325–31. doi: 10.1677/joe.0.1450325. [DOI] [PubMed] [Google Scholar]
  • 46.Campbell PI, Breedlove DK, Kempson SA. Insulin-like growth factor I stimulates sodium-phosphate cotransport in the rat osteoblastic cell line UMR-106-01. Am J Physiol. 1992;262(4 Pt 1):E389–93. doi: 10.1152/ajpendo.1992.262.4.E389. [DOI] [PubMed] [Google Scholar]
  • 47.Dong H, Maddux BA, Altomonte J, Meseck M, Accili D, Terkeltaub R, et al. Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes. 2005;54:367–72. doi: 10.2337/diabetes.54.2.367. [DOI] [PubMed] [Google Scholar]
  • 48.Huffman NT, Keightley JA, Chaoying C, Midura RJ, Lovitch D, Veno PA, et al. Association of specific proteolytic processing of bone sialoprotein and bone acidic glycoprotein-75 with mineralization within biomineralization foci. J Biol Chem. 2007;282:26002–13. doi: 10.1074/jbc.M701332200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol. 2009 Feb 12; doi: 10.1161/ATVBAHA.108.183384. [electronic publication ahead of print] [DOI] [PubMed] [Google Scholar]
  • 50.Parreno J, Buckley-Herd G, de-Hemptinne I, Hart DA. Osteoblastic MG-63 cell differentiation, contraction, and mRNA expression in stress-relaxed 3D collagen I gels. Mol Cell Biochem. 2008 Jun 20; doi: 10.1007/s11010-008-9801-x. [electronic publication ahead of print] [DOI] [PubMed] [Google Scholar]
  • 51.Turecek C, Fratzl-Zelman N, Rumpler M, Buchinger B, Spitzer S, Zoehrer R, et al. Collagen cross-linking influences osteoblastic differentiation. Calcif Tissue Int. 2008;82:392–400. doi: 10.1007/s00223-008-9136-3. [DOI] [PubMed] [Google Scholar]
  • 52.Celic S, Chilco PJ, Zajac JD, Martin TJ, Findlay DM. A type I collagen substrate increases PTH/PTHrP receptor mRNA expression and suppresses PTHrP mRNA expression in UMR106-06 osteoblast-like cells. J Endocrinol. 1996;150:299–308. doi: 10.1677/joe.0.1500299. [DOI] [PubMed] [Google Scholar]
  • 53.Celic S, Katayama Y, Chilco PJ, Martin TJ, Findlay DM. I. Type, collagen influence on gene expression in UMR106-06 osteoblast-like cells is inhibited by genistein. J Endocrinol. 1998;158:377–88. doi: 10.1677/joe.0.1580377. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp Figures
1

RESOURCES